Detalhe da pesquisa
1.
Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws.
Acta Haematol
; 124(2): 79-85, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20639624
2.
Avascular necrosis of bone in leukemia and osteonecrosis of jaw by bisphosphonates.
J Oral Maxillofac Surg
; 67(12): 2701-3, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19926001
3.
Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximab.
J Craniomaxillofac Surg
; 42(4): 279-82, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23800756
4.
Reduced serum levels of Interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration.
Cytokine
; 43(2): 103-4, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18585926
5.
Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1.
Leuk Lymphoma
; 48(9): 1852-4, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17786724
6.
Immunohistochemial evaluation of sarcoglycans and integrins in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw.
Oncol Rep
; 24(1): 129-34, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20514453